Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Published in: Journal of Nuclear Cardiology 5/2021

01-10-2021 | Endocarditis | EDITORIAL

Revisiting the relevance of the 3-month safety period in the evaluation of prosthetic valve endocarditis with FDG-PET/CT

Authors: Daniel Juneau, MD, Matthieu Pelletier-Galarneau, MD, MSc

Published in: Journal of Nuclear Cardiology | Issue 5/2021

Login to get access

Excerpt

Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) is the workhorse of nuclear oncology. One of the main limitations of FDG-PET/CT in oncology is the non-specific tracer uptake associated with infection and inflammation. In nuclear cardiology, this limitation has been put to good use and the role of FDG-PET/CT has drastically expended over the past years. Indeed, FDG-PET/CT has proven very useful in the evaluation of inflammation related to cardiac sarcoidosis1,2 and vasculitis.3 Furthermore, FDG-PET/CT has also been shown to play an important role in the evaluation of infection such as cardiovascular implantable electronic devices (CIED) infections.4,5 …
Literature
1.
Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI–ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017;58:1341-53.CrossRef
2.
Martineau P, Pelletier-Galarneau M, Juneau D, Leung E, Birnie D, Beanlands RSB. Molecular imaging of cardiac sarcoidosis. Curr Cardiovasc Imaging Rep 2018;11:6.CrossRef
3.
Pelletier-Galarneau M, Ruddy TD. PET/CT for diagnosis and management of large-vessel vasculitis. Curr Cardiol Rep 2019;21:34.CrossRef
4.
Sarrazin J-F, Philippon F, Tessier M, et al. Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections. J Am Coll Cardiol 2012;59:1616-25.CrossRef
5.
Kim J, Feller ED, Chen W, Dilsizian V. FDG PET/CT imaging for LVAD associated infections. JACC Cardiovasc Imaging 2014;7:839-42.CrossRef
6.
Habib G, Lancellotti P, Antunes MJ, et al. ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128.CrossRef
7.
Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374-82.CrossRef
8.
Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol 2019;26:922-35.CrossRef
9.
Juneau D, Golfam M, Hazra S, et al. Molecular Imaging for the diagnosis of infective endocarditis: A systematic literature review and meta-analysis. Int J Cardiol 2017;253:183-8.CrossRef
10.
11.
Swart LE, Gomes A, Scholtens AM, et al. Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography in prosthetic heart valve endocarditis. Circulation 2018;138:1412-27.CrossRef
12.
13.
Roque A, Pizzi MN, Fernández-Hidalgo N, et al. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: “normality” is a possible diagnosis. Eur Heart J Cardiovasc Imaging 2020;21:24-33.CrossRef
14.
Mumme T, Reinartz P, Alfer J, Müller-Rath R, Buell U, Wirtz D. Diagnostic values of positron emission tomography versus triple-phase bone scan in hip arthroplasty loosening. Arch Orthop Trauma Surg 2005;125:322-9.CrossRef
15.
Hariri H, Tan S, Martineau P, et al. Utility of FDG-PET/CT for the detection and characterization of sternal wound infection following sternotomy. Nucl Med Mol Imaging 2019;53:253-62.CrossRef
16.
Tang R, Wang JT-Y, Wang L, et al. Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: A systematic review and meta-analysis. Clin Nucl Med 2016;41:e327-39.CrossRef
17.
Dilsizian V, Bacharach SL, Beanlands RS, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187-226.CrossRef
Metadata
Title
Revisiting the relevance of the 3-month safety period in the evaluation of prosthetic valve endocarditis with FDG-PET/CT
Authors
Daniel Juneau, MD
Matthieu Pelletier-Galarneau, MD, MSc
Publication date
01-10-2021
Publisher
Springer International Publishing
Keyword
Endocarditis
Published in
Journal of Nuclear Cardiology / Issue 5/2021
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02070-y

Other articles of this Issue 5/2021

Journal of Nuclear Cardiology 5/2021 Go to the issue

Editorial

SPECT-derived absolute myocardial perfusion measures: A step in the right direction

Editorial

123I-MIBG cardiac sympathetic imaging provides further insight into cardiorenal interactions in systolic heart failure patients

Editorial

Using a sledgehammer to crack a nut: The burdensome appropriate use criteria program

Correction

Correction to: Does quantification of [11C]meta-hydroxyephedrine and [13N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy

Brief Report

Stress testing and myocardial perfusion imaging for patients after recovery from severe COVID-19 infection requiring hospitalization: A single-center experience

Original Article

No changes in myocardial perfusion following radiation therapy of left-sided breast cancer: A positron emission tomography study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits